Expect immediate selling pressure as the market prices in massive dilution. Monitor for the shareholder meeting date and effectiveness of the resale registration statement, which will unlock warrant-related overhang. The company's Nasdaq listing is at risk if the bid price remains below $1.00, adding delisting uncertainty.
Price Chart
Executive Summary
CollPlant Biotechnologies is conducting a dilutive PIPE offering of shares and warrants at $0.34 per share, with Series A (100% coverage, 2-year) and Series B (200% coverage, 5-year) warrants at the same exercise price. The offering size is undisclosed but likely substantial relative to the $5M market cap, requiring shareholder approval to increase authorized shares. This capital raise signals acute cash needs for a pre-revenue biotech already flagged for Nasdaq bid-price non-compliance.
Key Facts
- Offering of shares and warrants at $0.34 per share via a Securities Purchase Agreement dated June 29, 2026.
- Series A warrants cover 100% of shares purchased (2-year term, $0.34 exercise price); Series B warrants cover 200% (5-year term, $0.34 exercise price).
- Placement agent is H.C. Wainwright & Co., LLC.
- Shareholder approval required to increase authorized shares for warrant exercise.
- Company previously disclosed Nasdaq bid-price deficiency (closing bid below $1.00 for 30 consecutive business days).
- 12,803,006 ordinary shares outstanding as of December 31, 2025 (per 20-F).
Financial Impact
Undisclosed offering size; at $0.34/share with 300% warrant coverage, potential dilution could exceed 3x current shares outstanding if fully exercised, severely impacting existing holders.
Risk Factors
- Massive dilution from shares and warrants could push stock price lower.
- Nasdaq delisting risk due to continued bid-price deficiency.
- Need for further capital raises if proceeds are insufficient to fund operations.
- Shareholder approval may be delayed or denied, creating execution risk.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001213900-26-074017 |
| Document: ea029651901ex10-5.htm | 0001213900-26-074017 |
| Document: ea029651901ex10-4.htm | 0001213900-26-074017 |
| Document: ea029651901ex10-2.htm | 0001213900-26-074017 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 27, 2026 today | 144 | $3.78 | awaiting T+1 | — | $3.90 (+3.17%) |
Oct 19, 2026 8d ago | 3 | $3.88 $3.76 | ▼ −3.22% | ▼ −3.75% | $3.90 (+0.52%) |
Oct 15, 2026 12d ago | 6-K | $3.68 $3.63 | ▲ +1.49% | ▲ +0.39% | $3.90 (−5.98%) |
Oct 9, 2026 18d ago | 6-K | $4.02 $3.91 | ▲ +2.74% | ▲ +2.72% | $3.90 (+2.99%) |
Oct 8, 2026 19d ago | SC 13G | $3.97 $3.51 | ▼ −11.59% | ▼ −12.19% | $3.90 (−1.76%) |
Oct 8, 2026 19d ago | SC 13D/A | $3.97 $3.51 | ▼ −11.59% | ▼ −12.19% | $3.90 (−1.76%) |
Oct 6, 2026 21d ago | 6-K | $3.39 $3.46 | ▲ +2.06% | ▲ +2.30% | $3.90 (+15.04%) |
Sep 30, 2026 27d ago | 6-K | $3.57 $3.46 | ▲ +3.08% | ▲ +3.82% | $3.90 (−9.24%) |
Sep 30, 2026 27d ago | Press Release | $3.57 $3.46 | ▲ +3.08% | ▲ +3.82% | $3.90 (−9.24%) |
Sep 24, 2026 4w ago | 6-K | $4.12 $4.25 | ▲ +3.16% | ▲ +2.61% | $3.90 (−5.34%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers